沉默的羔羊

Indonesia bans syrup medicines as children die_我的网站

爱与罚

A | Jakarta, Oct 20 (UNI) The deaths of nearly 100 children in Indonesia has prompted the country to suspend sales of all syrup and liquid medication.
It comes just weeks after a cough syrup in The Gambia was linked to the deaths of nearly 70 children, reports BBC.
Indonesia said some syrup medicine was found to contain ingredients linked to acute kidney injuries (AKI), which have killed 99 young children this year.
It was not clear if the medicine were imported or locally produced.
On Thursday, Indonesian health officials said they had reported around 200 cases of AKI in children, most of who were aged under five, the BBC reported.
Earlier this month, the The World Health Organization (WHO) issued a global alert over four cough syrups that were linked to the deaths of almost 70 children in The Gambia.
The WHO found the syrups used there -- made by an Indian pharmaceutical company -- contained "unacceptable amounts" of diethylene glycol and ethylene glycol. The syrups have been "potentially linked with acute kidney injuries", said the organisation.
Indonesia's Health Minister on Thursday said the same chemical compounds were also found in some medicines used locally.
"Some syrups that were used by AKI child patients under five were proven to contain ethylene glycol and diethylene glycol that were not supposed to be there, or of very little amount," said Budi Gunadi Sadikin. He did not disclose how many cases involved the toxic medicines.
Indonesian authorities said the cough syrups used in The Gambia were not sold locally.
Indonesian authorities have so far not disclosed the brands or types of syrup medicines linked to sick children - instead just temporarily banning the sale and prescription of all syrup and liquid medicines.
UNI MR。　　这个时代，变数不断！　　今天，Anthropic最强AI曝出利空。Anthropic旗下最强、定价最高的Fable 5发布逾两个月，但买单者并不多。企业客户对Fable 5的消费支出仅占Anthropic旗下所有产品的11%，成长近乎停滞，甚至遭自家低价模型Opus 5超车。

B | 　　分析师与Anthropic投资人认为，关键原因在于Fable 5价格高昂，而旧版、较便宜的模型，实际上已足以处理多数企业工作。OpenAI的GPT5.6定价明显低于Fable 5。好模型的价格起不来，其商业价值、开发前景和大模型现金流预期亦会发生大变化。　　Fable 5 是由 Anthropic 于2026年6月发布的大型语言模型，代表了当时其产品线中能力最强、定位最高的旗舰级（Mythos级）AI。

C | 它在软件工程、科学研究及复杂推理等前沿基准测试中处于领先地位，但由于价格昂贵、性价比相对较低，在企业端的实际采用率表现平平。　　成长动能停滞　　据英国《金融时报》报道，支付机构Ramp追踪7万家企业支出数据发现，Fable 5自今年6月初发布以来，企业对其消费支出占Anthropic旗下全线产品的比例仅约11%，且近期成长动能明显停滞。反观Anthropic自家定价较低、规模较小的Opus 5，自7月底推出后，企业支出已超越Fable 5，显示企业选择AI模型时，正逐渐从单纯追求最强性能，转向衡量价格与实际需求。　　近期，大模型的价格战明显加剧。OpenAI的GPT5.6定价明显低于Fable5，其母公司本季迄今年化营收已成长35%，突破400亿美元；另一方面，价格更低的开源模型持续增加，也让企业客户拥有更多选择，进一步压缩美国顶尖AI实验室的定价空间。　　Fable5先前还受到政策因素干扰。

D | 特朗普政府6月初以国家安全为由，迫使Anthropic暂时撤回模型，冲击公司当月营收成长，直到7月1日获准重新上线。

E | 不过分析师与投资人指出，随着限制解除，政治不确定性对企业选择模型的影响已降低，价格与性能重新成为主要考量。　　Accel合伙人Miles Clements表示，大多数企业其实并不需要在最前沿的模型水准上运行，企业客户一味选择最强模型的时代，“并非一个可持续的阶段”。

F | 这项转变对Anthropic尤其敏感，因为前沿AI实验室长期投入数十亿美元研发资金，训练规模更大、更复杂的模型，并期待透过顶级模型的高定价收回成本。若企业客户持续转向价格较低、性能“够用”的产品，这套“以最强模型驱动营收”的逻辑可能面临根本挑战。　　Anthropic 7月年化营收达650亿美元，高于5月的470亿美元，但低于部分投资人原先预期的800亿美元以上。

G | 在Anthropic筹备IPO、外界预期估值可能达2万亿美元以上之际，Fable5的企业采用情况也成为市场观察焦点。　　芯片仍在“吸金”　　近期，虽然AI利空不断，产业链亦持续调整，但仍有大额资金涌入。半导体股就是AI投资热潮的核心受益者。　　根据晨星数据，追踪芯片股的最大杠杆ETF Direxion Daily Semiconductor Bull 3X Shares，在7月及8月前两周吸引近70亿美元资金净流入。该ETF提供纽约证券交易所半导体指数3倍杠杆曝险，涵盖30家美国芯片公司；其间标的指数从高点回落仅20%出头，该基金跌幅却高达70%。

H | 　　南方东英旗下两倍做多SK海力士一度出现高达86%的回撤，过去六周却仍吸引逾10亿美元资金流入。另一只追踪闪迪（SanDisk）的杠杆ETF同期也获得3.5亿美元净流入，闪迪股价仅7月就暴跌46%，相关杠杆产品从6月高点至7月低点更一度重挫85%，仍未阻止投资人进场押注反弹。截至8月12日，今年新成立的杠杆ETF已达303只，逼近2025年创下的324只历史纪录。